Bank Julius Baer & Co. Ltd, Zurich Dexcom Inc Transaction History

Bank Julius Baer & Co. Ltd, Zurich

$25.6 Billion
Q3 2024

A detailed history of Bank Julius Baer & Co. Ltd, Zurich transactions in Dexcom Inc stock. As of the latest transaction made, Bank Julius Baer & Co. Ltd, Zurich holds 93,840 shares of DXCM stock, worth $7.12 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

93,840

Previous 100,662 6.78%

Holding current value

$7.12 Million

Previous $11.4 Million 44.9%

% of portfolio

0.02%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $436,608 - $791,761	-6,822 Reduced 6.78%	93,840 $6.29 Million
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $844,202 - $1.07 Million	-7,653 Reduced 7.07%	100,662 $11.4 Million
Q1 2024 May 14, 2024	BUY	$114.22 - $140.1 $7.1 Million - $8.71 Million	62,146 Added 134.61%	108,315 $15 Million
Q4 2023 May 16, 2024	SELL	$75.49 - $124.16 $1.29 Million - $2.12 Million	-17,039 Reduced 26.96%	46,169 $5.73 Million
Q4 2023 May 16, 2024	SELL	$75.49 - $124.16 $3.41 Million - $5.6 Million	-45,107 Reduced 41.64%	63,208 $7.84 Million
Q4 2023 Feb 02, 2024	SELL	$75.49 - $124.16 $112,102 - $184,377	-1,485 Reduced 3.12%	46,169 $5.73 Million
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $28,571 - $45,792	332 Added 0.7%	47,654 $4.45 Million
Q2 2023 Jul 24, 2023	BUY	$112.47 - $130.98 $5.32 Million - $6.2 Million	47,322 New	47,322 $6.08 Million
Q1 2023 May 11, 2023	SELL	$104.0 - $122.92 $330,096 - $390,148	-3,174 Reduced 8.66%	33,473 $3.89 Million
Q4 2022 Jan 24, 2023	BUY	$84.98 - $122.67 $3,569 - $5,152	42 Added 0.11%	36,647 $4.15 Million
Q3 2022 Nov 04, 2022	BUY	$76.35 - $94.18 $16,491 - $20,342	216 Added 0.59%	36,605 $2.95 Million
Q2 2022 Jul 22, 2022	BUY	$67.99 - $132.89 $1.87 Million - $3.65 Million	27,442 Added 306.72%	36,389 $2.71 Million
Q1 2022 May 09, 2022	BUY	$94.08 - $130.2 $63,127 - $87,364	671 Added 8.11%	8,947 $4.58 Million
Q4 2021 Feb 15, 2022	BUY	$129.87 - $162.82 $135,064 - $169,332	1,040 Added 14.37%	8,276 $4.44 Million
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $127,945 - $171,672	1,199 Added 19.86%	7,236 $3.96 Million
Q2 2021 Jul 23, 2021	SELL	$80.99 - $107.93 $101,480 - $135,236	-1,253 Reduced 17.19%	6,037 $2.58 Million
Q1 2021 May 10, 2021	BUY	$84.79 - $104.74 $224,778 - $277,665	2,651 Added 57.15%	7,290 $2.62 Million
Q4 2020 Feb 24, 2021	SELL	$78.0 - $104.5 $6.22 Million - $8.34 Million	-79,796 Reduced 94.51%	4,639 $1.72 Million
Q4 2020 Feb 12, 2021	BUY	$78.0 - $104.5 $6.44 Million - $8.62 Million	82,521 Added 4311.44%	84,435 $1.72 Million
Q3 2020 Nov 10, 2020	BUY	$95.51 - $112.95 $182,806 - $216,186	1,914 New	1,914 $789,000

Others Institutions Holding DXCM

# of Institutions

1,013

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.

Account

Bank Julius Baer & Co. Ltd, Zurich Dexcom Inc Transaction History